| Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis H Yu, MR Spitz, J Mistry, J Gu, WK Hong, X Wu Journal of the National Cancer Institute 91 (2), 151-156, 1999 | 729 | 1999 |
| Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma IF Khouri, MS Lee, RM Saliba, G Jun, L Fayad, A Younes, B Pro, ... Journal of Clinical Oncology 21 (23), 4407-4412, 2003 | 259 | 2003 |
| Benzo(a)pyrene Diol Epoxide-induced Chromosomal Aberrations and Risk of Lung Cancer Q Wei, J Gu, L Cheng, ML Bondy, H Jiang, WK Hong, MR Spitz Cancer research 56 (17), 3975-3979, 1996 | 136 | 1996 |
| Molecular epidemiology of primary brain tumors J Gu, Y Liu, AP Kyritsis, ML Bondy Neurotherapeutics 6 (3), 427-435, 2009 | 128 | 2009 |
| A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls X Wu, J Gu, CI Amos, H Jiang, WK Hong, MR Spitz Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 82 | 1998 |
| Mutagen sensitivity and risk of gliomas: a case-control analysis ML Bondy, AP Kyritsis, J Gu, M De Andrade, J Cunningham, VA Levin, ... Cancer research 56 (7), 1484-1486, 1996 | 76 | 1996 |
| DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Q Wei, MR Spitz, J Gu, L Cheng, X Xu, SS Strom, ML Kripke, TC Hsu Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1996 | 71 | 1996 |
| The utility of interphase fluorescence in situ hybridization for the detection of the translocation t (11; 14)(q13; q32) in the diagnosis of mantle cell lymphoma on fine‐needle … NP Caraway, J Gu, P Lin, JE Romaguera, A Glassman, R Katz Cancer Cytopathology: Interdisciplinary International Journal of the …, 2005 | 66 | 2005 |
| Benzo[a]pyrene Diol Epoxide and Bleomycin Sensitivity and Susceptibility to Cancer of Upper Aerodigestive Tract X Wu, J Gu, WK Hong, JJ Lee, CI Amos, H Jiang, RJ Winn, K King-Wah Fu, ... JNCI: Journal of the National Cancer Institute 90 (18), 1393-1399, 1998 | 66 | 1998 |
| Centrosomal abnormality is common in and a potential biomarker for bladder cancer F Jiang, NP Caraway, AL Sabichi, HZ Zhang, A Ruitrok, HB Grossman, ... International journal of cancer 106 (5), 661-665, 2003 | 63 | 2003 |
| Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. X Wu, J Gu, Y Patt, M Hassan, MR Spitz, RP Beasley, LY Hwang Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1998 | 57 | 1998 |
| Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization: a useful ancillary method for the diagnosis of mantle cell lymphoma RL Katz, NP Caraway, J Gu, F Jiang, LA Pasco-Miller, AB Glassman, ... American journal of clinical pathology 114 (2), 248-257, 2000 | 50 | 2000 |
| Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization HJC Shin, P Thorson, J Gu, RL Katz Diagnostic cytopathology 29 (2), 61-66, 2003 | 34 | 2003 |
| Ethnic differences in poly (ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk J Gu, MR Spitz, F Yang, X Wu Carcinogenesis 20 (8), 1465-1470, 1999 | 33 | 1999 |
| Three measures of mutagen sensitivity in a cancer-free population J Gu, ML Bondy, A Sigurdson, MR Spitz, TC Hsu, X Wu Cancer genetics and cytogenetics 110 (1), 65-69, 1999 | 24 | 1999 |
| t (3; 8)(q26. 2; q24) often leads to MECOM/MYC rearrangement and is commonly associated with therapy-related myeloid neoplasms and/or disease progression G Tang, S Hu, SA Wang, W Xie, P Lin, J Xu, G Toruner, M Zhao, J Gu, ... The Journal of Molecular Diagnostics 21 (2), 343-351, 2019 | 21 | 2019 |
| Gamma-ray mutagen sensitivity and survival in patients with glioma. AJ Sigurdson, ML Bondy, KR Hess, SA Toms, AP Kyritsis, J Gu, LE Wang, ... Clinical cancer research: an official journal of the American Association …, 1998 | 16 | 1998 |
| Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations Z Tang, G Tang, S Hu, KP Patel, CC Yin, W Wang, P Lin, GA Toruner, ... Cancer Genetics 233, 21-31, 2019 | 15 | 2019 |
| Fluorescence in situ hybridization probe validation for clinical use J Gu, JL Smith, PK Dowling Cancer Cytogenetics: Methods and Protocols, 101-118, 2017 | 14 | 2017 |
| Coexistence of iAMP21 and ETV6-RUNX1 fusion in an adolescent with B cell acute lymphoblastic leukemia: literature review of six additional cases J Gu, A Reynolds, L Fang, C DeGraffenreid, K Sterns, KP Patel, ... Molecular Cytogenetics 9, 1-10, 2016 | 14 | 2016 |
